Fujian Cosunter Pharmaceutical Co Ltd Class A 300436
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥20.08
- Day Range
- ¥20.52–23.58
- 52-Week Range
- ¥14.16–31.84
- Bid/Ask
- ¥23.14 / ¥23.15
- Market Cap
- ¥3.69 Bil
- Volume/Avg
- 13.0 Mil / 7.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.90
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 820
- Website
- http://www.cosunter.com
Comparables
Valuation
|
Metric
|
300436
|
002424
|
600285
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 29.42 | 20.28 |
Price/Book Value | 6.66 | 1.46 | 4.75 |
Price/Sales | 6.90 | 1.15 | 3.64 |
Price/Cash Flow | — | — | 17.45 |
Price/Earnings
300436
002424
600285
Financial Strength
|
Metric
|
300436
|
002424
|
600285
|
|---|---|---|---|
Quick Ratio | 0.38 | 0.77 | 0.77 |
Current Ratio | 0.77 | 1.13 | 1.08 |
Interest Coverage | −4.11 | −8.65 | — |
Quick Ratio
300436
002424
600285
Profitability
|
Metric
|
300436
|
002424
|
600285
|
|---|---|---|---|
Return on Assets (Normalized) | −15.51% | −7.17% | 13.60% |
Return on Equity (Normalized) | −44.17% | −14.34% | 23.41% |
Return on Invested Capital (Normalized) | −20.90% | −8.90% | 21.59% |
Return on Assets
300436
002424
600285
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tppxbbypj | Jyfl | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Ncbwxrsp | Rlybkww | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Tqjqllj | Gdnd | $48.4 Bil | |||
| Viatris Inc
VTRS
| Xpvpjqwlx | Byc | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Kltjtgcsm | Tpjmk | $13.5 Bil | |||
| Catalent Inc
CTLT
| Pzkvnspgr | Hpygv | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Xhgwxkrbj | Vnvhyd | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Ntwslbp | Lmskt | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rjctdvjsv | Xllt | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Wwmzjxtt | Szcv | $2.3 Bil |
United States